Truist Securities analysts reiterated a Hold rating on Edwards Lifesciences Corporation (NYSE:EW) on February 11, 2026.
Edwards Lifesciences Corporation operates in the Healthcare sector. The stock currently trades at $75.87 with a market capitalization of $49.5B.